Nancy Taylor is Co-Chair of the Health Care & FDA Practice and focuses her practice on health and FDA related matters. She has broad experience working with providers, plans, employers, private equity firms, and FDA regulated companies. She advises clients on health care transactions, health and FDA regulatory policy and compliance, and responding to Congressional and Administration investigations and audits. Prior to joining Greenberg Traurig, Nancy served 10 years as Health Policy Director for a Senate Committee and worked on a number of significant health and FDA laws. She also served as CEO of a start-up medical device company, where she obtained eight product clearances, including securing reimbursement coverage for each product.

Nancy E. Taylor
Professional Bio
Rep. Mike Johnson Elected House Speaker: Where He Stands on Major Policies
Hot Off The Hill ·
Rep. Mike Johnson Elected House Speaker: Where He Stands on Major Policies
Hot Off The Hill ·
Mandatory or Voluntary Employee Vaccinations: EEOC Weighs In
GT Israel Law Blog ·
EEOC Issues Updated Guidance on COVID-19 Antibody Testing
Employment & Labor ·